Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 4 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2017 Filed Jun 26, 2017 20:52 UTC Amendment |
APPELROUTH STEWARTDirector
|
GrantOptions to buy Common Stock · Derivative | 13,238 | $0.57 Strike: $0.64 | $7,545.66 |
DisclosureSEC source: 0001191434-17-000002 · primary_doc.xml · derivative · entry 2 Appelrouth Stewart · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,238 Underlying: Common Stock · 13,238 shares Expires 2027-05-15 F1 · security: Correction to footnote from original filing on 6/26/17: This option is being issued in exchange for a voluntary 100% reduction in Director's Fees. F1 · price: Correction to footnote from original filing on 6/26/17: This option is being issued in exchange for a voluntary 100% reduction in Director's Fees. Read SEC document |
| May 15, 2017 Filed Jun 26, 2017 20:34 UTC |
MITCHELL WILLIAM MDirector
|
GrantOptions to buy Common Stock · Derivative | 13,238 | $0.57 Strike: $0.64 | $7,545.66 |
DisclosureSEC source: 0001191434-17-000001 · primary_doc.xml · derivative · entry 2 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,238 Underlying: Common Stock · 13,238 shares Expires 2027-05-15 F1 · security: This option is being issued in exchange for a voluntary 100% reduction in Director's Fees. F1 · price: This option is being issued in exchange for a voluntary 100% reduction in Director's Fees. Read SEC document |
| May 15, 2017 Filed Jun 26, 2017 15:09 UTC |
APPELROUTH STEWARTDirector
|
GrantOptions to buy Common Stock · Derivative | 13,238 | $0.57 Strike: $0.64 | $7,545.66 |
DisclosureSEC source: 0001702626-17-000003 · primary_doc.xml · derivative · entry 2 Appelrouth Stewart · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,238 Underlying: Common Stock · 13,238 shares Expires 2027-05-15 F1 · security: This option is being issued in exchange for a voluntary 100% reduction in salary. F1 · price: This option is being issued in exchange for a voluntary 100% reduction in salary. Read SEC document |
| May 02, 2017 Filed May 2, 2017 18:31 UTC |
STRAYER DAVID RChief Science/Medical Officer
|
PurchaseCommon Stock | 7,937 | $0.63 | $5,000.31 |
DisclosureSEC source: 0001613377-17-000006 · primary_doc.xml · nonDerivative · entry 1 STRAYER DAVID R · CIK 0001270074 · Chief Science/Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,804 Read SEC document |
| May 02, 2017 Filed May 2, 2017 18:09 UTC |
PASCALE ADAMCFO
|
PurchaseCommon Stock | 15,873 | $0.63 | $9,999.99 |
DisclosureSEC source: 0001613377-17-000005 · primary_doc.xml · nonDerivative · entry 1 Pascale Adam · CIK 0001613377 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,389 Read SEC document |
| May 02, 2017 Filed May 3, 2017 16:50 UTC |
Rodino Peter W IIIExec Dir Govt Relations/Secrty
|
PurchaseCommon Stock | 15,873 | $0.63 | $9,999.99 |
DisclosureSEC source: 0001583701-17-000001 · primary_doc.xml · nonDerivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Exec Dir Govt Relations/Secrty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,873 Read SEC document |
| May 02, 2017 Filed May 3, 2017 15:33 UTC |
SPRINGATE WAYNE SSr VP of Operations
|
PurchaseCommon Stock | 15,873 | $0.63 | $9,999.99 |
DisclosureSEC source: 0001465652-17-000001 · primary_doc.xml · nonDerivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,514 Read SEC document |
| April 30, 2017 Filed Jun 26, 2017 20:52 UTC Amendment |
APPELROUTH STEWARTDirector
|
GrantOptions to buy Common Stock · Derivative | 12,644 | $0.60 Strike: $0.67 | $7,586.40 |
DisclosureSEC source: 0001191434-17-000002 · primary_doc.xml · derivative · entry 1 Appelrouth Stewart · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,644 Underlying: Common Stock · 12,644 shares Expires 2027-04-30 F1 · security: Correction to footnote from original filing on 6/26/17: This option is being issued in exchange for a voluntary 100% reduction in Director's Fees. F1 · price: Correction to footnote from original filing on 6/26/17: This option is being issued in exchange for a voluntary 100% reduction in Director's Fees. Read SEC document |
| April 30, 2017 Filed Jun 26, 2017 20:34 UTC |
MITCHELL WILLIAM MDirector
|
GrantOptions to buy Common Stock · Derivative | 12,644 | $0.60 Strike: $0.67 | $7,586.40 |
DisclosureSEC source: 0001191434-17-000001 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,644 Underlying: Common Stock · 12,644 shares Expires 2027-04-30 F1 · security: This option is being issued in exchange for a voluntary 100% reduction in Director's Fees. F1 · price: This option is being issued in exchange for a voluntary 100% reduction in Director's Fees. Read SEC document |
| April 30, 2017 Filed Jun 26, 2017 15:09 UTC |
APPELROUTH STEWARTDirector
|
GrantOptions to buy Common Stock · Derivative | 12,644 | $0.60 Strike: $0.67 | $7,586.40 |
DisclosureSEC source: 0001702626-17-000003 · primary_doc.xml · derivative · entry 1 Appelrouth Stewart · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,644 Underlying: Common Stock · 12,644 shares Expires 2027-04-30 F1 · security: This option is being issued in exchange for a voluntary 100% reduction in salary. F1 · price: This option is being issued in exchange for a voluntary 100% reduction in salary. Read SEC document |
| April 27, 2017 Filed Apr 27, 2017 13:27 UTC |
Equels Thomas KDirector · CEO, President
|
PurchaseCommon Stock | 72,464 | $0.69 | $50,000.16 |
DisclosureSEC source: 0001450324-17-000002 · primary_doc.xml · nonDerivative · entry 1 Equels Thomas K. · CIK 0001450324 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,919 Read SEC document |
| April 11, 2017 Filed Apr 11, 2017 13:54 UTC |
Equels Thomas KDirector · CEO, President
|
PurchaseCommon Stock | 200,000 | $0.50 | $100,000.00 |
DisclosureSEC source: 0001450324-17-000001 · primary_doc.xml · nonDerivative · entry 1 Equels Thomas K. · CIK 0001450324 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,455 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 20:31 UTC Amendment |
SPRINGATE WAYNE SSr VP of Operations
|
PurchaseCommon Stock | 8,014 | $0.46 | $3,686.44 |
DisclosureSEC source: 0001613377-17-000004 · primary_doc.xml · nonDerivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,641 F1 · balance_after: The amount of securities beneficially owned following the reported transaction was incorrect when filed earlier today (2/21/17). Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 18:26 UTC |
SPRINGATE WAYNE SSr VP of Operations
|
PurchaseCommon Stock | 8,014 | $0.46 | $3,686.44 |
DisclosureSEC source: 0001613377-17-000002 · primary_doc.xml · nonDerivative · entry 1 Springate Wayne S. · CIK 0001465652 · Sr VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,989 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 19:15 UTC |
STRAYER DAVID RChief Science/Medical Officer
|
PurchaseCommon Stock | 9,892 | $0.46 | $4,550.32 |
DisclosureSEC source: 0001613377-17-000003 · primary_doc.xml · nonDerivative · entry 1 STRAYER DAVID R · CIK 0001270074 · Chief Science/Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,867 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:33 UTC |
PASCALE ADAMCFO
|
PurchaseCommon Stock | 6,981 | $0.46 | $3,211.26 |
DisclosureSEC source: 0001613377-17-000001 · primary_doc.xml · nonDerivative · entry 1 Pascale Adam · CIK 0001613377 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,516 Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 17:31 UTC |
Equels Thomas KDirector · CEO, President
|
PurchaseCommon Stock | 68,493 | $0.73 | $49,999.89 |
DisclosureSEC source: 0001450324-16-000016 · primary_doc.xml · nonDerivative · entry 1 Equels Thomas K. · CIK 0001450324 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,455 Read SEC document |
| November 01, 2016 Filed Nov 1, 2016 17:27 UTC |
Equels Thomas KDirector · CEO,President
|
PurchaseCommon Stock | 10,000 | $1.00 | $10,000.00 |
DisclosureSEC source: 0001450324-16-000015 · primary_doc.xml · nonDerivative · entry 1 Equels Thomas K. · CIK 0001450324 · Director · CEO,President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,962 Read SEC document |
| August 24, 2016 Filed Mar 31, 2017 18:43 UTC |
APPELROUTH STEWARTDirector
|
PurchaseCommon Stock | 15,750 | $2.21 | $34,807.50 |
DisclosureSEC source: 0001702626-17-000002 · primary_doc.xml · nonDerivative · entry 1 Appelrouth Stewart · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 F1 · shares: Shares and prices have been adjusted to give retroactive effect to the 1 for 12 reverse stock split effected on 8/29/16. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.16 to $2.22. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.